Since ancient times, many scientists and doctors have used various herbs to treat diseases. Conventional drugs often have side effects, and pathogens are becoming resistant to these types of drugs. In such circumstances, the study of traditional medicinal plants is an effective and logical strategy for finding new herbal medicines. One such herb is Plantago major, a perennial plant in the Plantaginaceae family that is found throughout the world. The Plantago major plant has been used as a medicine for the treatment of various diseases. Studies have shown that plant extracts of Plantago major exhibit antimicrobial, antiviral, and anti-inflammatory effects, and have wound-healing properties. This review collects and presents the results of various studies of Plantago major plant extracts with antimicrobial, antiviral, antifungal, anti-inflammatory, and wound-healing properties, which demonstrate a wide range of therapeutic possibilities of Plantago major plant extracts and have a huge potential for use as a medicinal raw material.

The genus Anabasis is a member of the family Amaranthaceae (former name: Chenopodiaceae) and includes approximately 102 genera and 1400 species. The genus Anabasis is one of the most significant families in salt marshes, semi-deserts, and other harsh environments. They are also renowned for their abundance in bioactive compounds, including sesquiterpenes, diterpenes, triterpenes, saponins, phenolic acids, flavonoids, and betalain pigments. Since ancient times, these plants have been used to treat various diseases of the gastrointestinal tract, diabetes, hypertension, and cardiovascular diseases and are used as an antirheumatic and diuretic. At the same time, the genus Anabasis is very rich in biologically active secondary metabolites that exhibit great pharmacological properties such as antioxidant, antibacterial, antiangiogenic, antiulcer, hypoglycemic, hepatoprotective, antidiabetic, etc. All of the listed pharmacological activities have been studied in practice by scientists from different countries and are presented in this review article to familiarize the entire scientific community with the results of these studies, as well as to explore the possibilities of using four plant species of the genus Anabasis as medicinal raw materials and developing medicines based on them.

Elymus repens (L.) Gould, commonly known as couch grass, is mainly distributed as a medicinal herb of great ethnopharmacological importance. This review presented for the first time the significance of nomenclature clarity, current insights on distribution, traditional use, phytochemistry and their biological activities. The bioactive compound composition of E. repens displayed a variety of compounds including carbohydrates, phenolic acids, flavonoids, benzoxazinoids and volatile compounds, all of which contributed to its medicinal properties. The biological potential of this plant underlines diuretic, antiurolithiatic, anti-inflammatory, antioxidant and also antidiabetic qualities with molecular insights showing synergistic interactions across many compound classes. The current reported data notably confirmed its potential in lowering renal calculi and alleviating associated symptoms; however, the findings remain limited. E. repens’ medicinal potential is further confirmed by its historical application as an herbal tea and aqueous preparation, which clearly indicates its favorable safety profile. Along with this, from many encouraging results, there exist considerable deficiencies in standardization, clinical validation and also mechanistic clarification. This review highlights the necessity for careful studies to determine the therapeutic efficiency, enhance formulation and promote E. repens as a scientifically therapeutic agent.

Background: In the contemporary context, a factor in the successful development of pharmaceutical organizations is the active use of information and communication tools both for work with customers and suppliers, and in the internal processes of economic activity. On the one hand, the introduction of IT technology allows us to ensure compliance with the requirements of the legislation of the Republic of Kazakhstan. On the other hand, it opens up great opportunities for improving the level of service for pharmacy visitors, contributes to the formation of greater loyalty to a particular pharmacy organization and, therefore, makes it more competitive and cost-effective. Aim: development of an automated control system for the movement of pharmaceutical products in pharmacies. Materials And Methods: we used basic research, including an analysis of the external and internal information system of a pharmacy organization (ISPO); informatization processes in the pharmaceutical market, pharmacy resources; scientific approaches to the study - systemic, logical-structural, process, marketing, regional. The objects of the study were pharmacy organizations, pharmaceutical workers in pharmacies, and software products. Results and Discussion: To conduct the study, a design was developed that includes a research program to improve the information and communication activities of retail pharmaceutical organizations. Following the program, the authors developed a questionnaire survey to study the informational needs of pharmacy workers. Based on the results of the research, the main directions for the use of information technologies in pharmacy were determined. The authors compiled a portrait of an IT user and identified the strengths and weaknesses, opportunities and threats of using IT in pharmacies. Based on the Salesforce program, a modified system for controlling the movement of pharmaceutical products in pharmacies has been created.